Related references
Note: Only part of the references are listed.Nr5a2 promotes cancer stem cell properties and tumorigenesis in nonsmall cell lung cancer by regulating Nanog
Ting Ye et al.
CANCER MEDICINE (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Targeting Cancer Stemness in the Clinic: From Hype to Hope
Caner Saygin et al.
CELL STEM CELL (2019)
Prognostic evaluation of NANOG and OCT4 expression for posttransplantation hepatocellular carcinoma recurrence
Wenjuan Cai et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
Jianfang Liu et al.
CELL (2018)
Biological aspects of chondrosarcoma: Leaps and hurdles
Benoite Mery et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Association of Glioblastoma Multiforme Stem Cell Characteristics, Differentiation, and Microglia Marker Genes with Patient Survival
Sandra Bien-Moeller et al.
STEM CELLS INTERNATIONAL (2018)
Platelet-derived growth factor receptor-α and -β promote cancer stem cell phenotypes in sarcomas
Kevin K. Chang et al.
ONCOGENESIS (2018)
Role of Akt Isoforms Controlling Cancer Stem Cell Survival, Phenotype and Self-Renewal
Sergio Rivas et al.
BIOMEDICINES (2018)
Role of Rac1 Pathway in Epithelial-to-Mesenchymal Transition and Cancer Stem-like Cell Phenotypes in Gastric Adenocarcinoma
Changhwan Yoon et al.
MOLECULAR CANCER RESEARCH (2017)
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Tsukasa Shibue et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas
Alexander J. Lazar et al.
CELL (2017)
Chemotherapy Resistance in Diffuse-Type Gastric Adenocarcinoma Is Mediated by RhoA Activation in Cancer Stem-Like Cells
Changhwan Yoon et al.
CLINICAL CANCER RESEARCH (2016)
Multimodal targeting of tumor vasculature and cancer stem-like cells in sarcomas with VEGF-A inhibition, HIF-1α inhibition, and hypoxia-activated chemotherapy
Changhwan Yoon et al.
ONCOTARGET (2016)
Hypoxia-activated chemotherapeutic TH-302 enhances the effects of VEGF-A inhibition and radiation on sarcomas
C. Yoon et al.
BRITISH JOURNAL OF CANCER (2015)
Erk signaling is indispensable for genomic stability and self-renewal of mouse embryonic stem cells
Haixia Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Concise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding Questions
Collene R. Jeter et al.
STEM CELLS (2015)
The Cancer Stem Cell Hypothesis: A Guide to Potential Molecular Targets
Alessandro Allegra et al.
CANCER INVESTIGATION (2014)
Cancer stem-like cell characteristics induced by EB virus-encoded LMP1 contribute to radioresistance in nasopharyngeal carcinoma by suppressing the p53-mediated apoptosis pathway
Chang-Fu Yang et al.
CANCER LETTERS (2014)
CD44 Expression Denotes a Subpopulation of Gastric Cancer Cells in Which Hedgehog Signaling Promotes Chemotherapy Resistance
Changhwan Yoon et al.
CLINICAL CANCER RESEARCH (2014)
Transcription factor heterogeneity in pluripotent stem cells: a stochastic advantage
Maria-Elena Torres-Padilla et al.
DEVELOPMENT (2014)
The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis
X. Lu et al.
ONCOGENE (2014)
Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors
Jack F. Shern et al.
CANCER DISCOVERY (2014)
Prognostic Impact of the Activation Status of the Akt/mTOR Pathway in Synovial Sarcoma
Nokitaka Setsu et al.
CANCER (2013)
CD133+ subpopulation of the HT1080 human fibrosarcoma cell line exhibits cancer stem-like characteristics
Bao-Hua Feng et al.
ONCOLOGY REPORTS (2013)
Aldehyde Dehydrogenase 1 Identifies Cells with Cancer Stem Cell-Like Properties in a Human Renal Cell Carcinoma Cell Line
Kosuke Ueda et al.
PLOS ONE (2013)
Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance
L. Chang et al.
CELL DEATH & DISEASE (2013)
Exploring Novel Therapeutic Targets in GIST: Focus on the PI3K/Akt/mTOR Pathway
Shreyaskumar Patel
CURRENT ONCOLOGY REPORTS (2013)
Cancer stem cells in pediatric sarcomas
Filemon S. Dela Cruz
FRONTIERS IN ONCOLOGY (2013)
Cancer stem cells: In the line of fire
Malcolm R. Alison et al.
CANCER TREATMENT REVIEWS (2012)
Expression of therapeutic targets in Ewing sarcoma family tumors
Atif A. Ahmed et al.
HUMAN PATHOLOGY (2012)
Nanog signaling in cancer promotes stem-like phenotype and immune evasion
Kyung Hee Noh et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
c-Jun N-terminal kinase has a pivotal role in the maintenance of self-renewal and tumorigenicity in glioma stem-like cells
C-H Yoon et al.
ONCOGENE (2012)
Embryonic NANOG Activity Defines Colorectal Cancer Stem Cells and Modulates through AP1-and TCF-dependent Mechanisms
Elsayed E. Ibrahim et al.
STEM CELLS (2012)
CD24+ Liver Tumor-Initiating Cells Drive Self-Renewal and Tumor Initiation through STAT3-Mediated NANOG Regulation
Terence Kin Wah Lee et al.
CELL STEM CELL (2011)
Targeting the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cells
A. M. Martelli et al.
CURRENT MEDICINAL CHEMISTRY (2011)
NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation
C. R. Jeter et al.
ONCOGENE (2011)
Hypoxia Induces Tumor Aggressiveness and the Expansion of CD133-Positive Cells in a Hypoxia-Inducible Factor-1 alpha-Dependent Manner in Pancreatic Cancer Cells
Okito Hashimoto et al.
PATHOBIOLOGY (2011)
Expansion of CD133+ colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery
D. D. Fang et al.
BRITISH JOURNAL OF CANCER (2010)
miR-130b Promotes CD133+ Liver Tumor-Initiating Cell Growth and Self-Renewal via Tumor Protein 53-Induced Nuclear Protein 1
Stephanie Ma et al.
CELL STEM CELL (2010)
Expression of CD133 in Synovial Sarcoma
Jefferson Terry et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2010)
Soft tissue sarcoma cells are highly sensitive to AKT blockade:: A role for p53-independent up-regulation of GADD45α
Quan-Sheng Zhu et al.
CANCER RESEARCH (2008)
PDK-1/AKT pathway as a novel therapeutic target in rhabdomyosarcoma cells using OSU-03012 compound
L. Cen et al.
BRITISH JOURNAL OF CANCER (2007)
The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas
Eva Hernando et al.
NATURE MEDICINE (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
The cancer stem cell hypothesis: a work in progress
Brenton Thomas Tan et al.
LABORATORY INVESTIGATION (2006)
Prognostic significance of activated AKT expression in soft-tissue sarcoma
Yasuhiko Tomita et al.
CLINICAL CANCER RESEARCH (2006)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
Share Paper
